Cloverfields Capital Group, LP Novartis Ag Transaction History
Cloverfields Capital Group, LP
- $277 Million
- Q4 2024
A detailed history of Cloverfields Capital Group, LP transactions in Novartis Ag stock. As of the latest transaction made, Cloverfields Capital Group, LP holds 19,378 shares of NVS stock, worth $2.14 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
19,378
Previous 18,178
6.6%
Holding current value
$2.14 Million
Previous $2.09 Million
9.81%
% of portfolio
0.68%
Previous 0.74%
Shares
5 transactions
Others Institutions Holding NVS
# of Institutions
1,477Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.35 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.22 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$905 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$760 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$617 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $238B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...